Publications by authors named "C Fernandez de Larrea"

Article Synopsis
  • CAR T-cell therapy shows strong initial results for treating relapsed refractory multiple myeloma, but most patients eventually relapse, often within 5 months.
  • In a study of 139 patients who relapsed after CAR T-cell therapy, different salvage therapies were analyzed, revealing that bispecific antibodies, like talquetamab and teclistamab, had the best overall and complete response rates.
  • The presence of extramedullary disease at relapse was linked to poorer outcomes, but bispecific antibodies improved survival rates, suggesting they should be the standard treatment for patients relapsing after CAR T-cell therapy.
View Article and Find Full Text PDF

The impact of measurable residual disease (MRD) in relapse/refractory multiple myeloma (RRMM) patients treated with T-cell redirecting immunotherapy is uncertain. We analyzed MRD dynamics using next-generation flow in 201 patients treated in clinical trials with chimeric antigen receptor (CAR) T cells and T-cell engagers (TCE). Achieving MRD negativity at 10 was associated with 89% reduction in the risk of progression and/or death.

View Article and Find Full Text PDF

This research analyses 24 years of oil extraction in blocks 16 and 67 of the Yasuní National Park (YNP) in the Amazonian Forest of Ecuador, one of the most biodiverse spaces in the world and with the current presence of ancient indigenous communities. As a novel contribution, we have carried out a Life-Cycle Assessment (LCA) that quantifies the footprints associated with the extraction, transportation, refining, distribution and final uses of the oil in four different scenarios (oil for asphalt use, electricity, marine fuel and passenger car transport). This study also sheds light on the energy return at the point of use of different oil-derivatives, and complements this with a qualitative analysis of the social, cultural and environmental implications for the Waorani communities.

View Article and Find Full Text PDF

Hydrogels are receiving increasing attention for their use in 3D cell culture, tissue engineering, and bioprinting applications. Each application places specific mechanical and biological demands on these hydrogels. We developed a hydrogel toolbox based on enzymatically crosslinkable polysaccharides via tyramine (TA) moieties, allowing for rapid and tunable crosslinking with well-defined stiffness and high cell viability.

View Article and Find Full Text PDF